This website uses cookies to improve functionality and performance. With a click on the OK button you are giving implied consent to the use of cookies on this website.
More information
EnglishDeutsch
de
EnglishDeutsch
de
Login Environment Pharma

SOS Tuberculosis Screening

SYNLAB Outbreak Service (SOS) provides a reliable and cost effective screening service for Latent Tuberculosis Infection (LTBI)

LTBI screening is available for both outbreaks and community based screening programmes.

Using Qiagen's QuantiFERON-TB Gold Interferon Gamma Release assay (IGRA), synlab pharma institute provides an end-to-end service for LTBI screening

Services for QuantiFERON® Test include:

  • A dedicated TB Coordinator as main contact
  • Provision of QuantiFERON tubes for blood collection
  • On-site sample collection wirh a dedicated courier service
  • Sample transport
  • Sample analysis by an accredited synlab laboratory
  • Secure data transfer
Contact us



News & Events

View All
Fellbach wird neuer Laborstandort
Nach zweijähriger Planungs- und Umbauphase entstand in Fellbach das neue Labor der SYNLAB Analytics & Services Germany GmbH.
Aug 10, 2018 Continue
Determination of the Impurity N-Nitroso dimethyl amine (NDMA) in Drug Substances with GC-MS

Due to contamination of a drug substance with the potential mutagenic substance N-Nitroso dimethyl amine (NDMA) a massive recall campaign was initiated for the related drug products. SYNLAB Pharma offers a GC-MS test for testing the absence of NDMA in drug substances and drug products.

Please contact our experts.

Jul 13, 2018 | Pharma Continue
New Services in Regulatory Compliance for Biologics

With immediate effect, SYNLAB Pharma provides a broad support in the field of Regulatory Compliance of Biologics development. With this new services we support specifically start-ups, small to medium sized biotech companies, which require professional consultancy and project execution in regulatory project design.

For further questions, please contact:

pharma@synlab.com

Jun 18, 2018 | Pharma Continue
View All